The Social Vulnerability Index As a Risk Stratification Tool for Health Disparity Research in Cancer Patients: a Scoping Review

Overview

Journal Cancer Causes Control

Specialties Oncology
Public Health

Date 2023 Apr 7

PMID 37027053

Authors

Tiffaney Tran

Morgan A Rousseau

David P Farris

Cici Bauer

Kelly C Nelson

Hung Q Doan

Affiliations

Soon will be listed here.

Abstract

Purpose: The social vulnerability index (SVI), developed by the Centers for Disease Control and Prevention, is a novel composite measure encompassing multiple variables that correspond to key social determinants of health. The objective of this review was to investigate innovative applications of the SVI to oncology research and to employ the framework of the cancer care continuum to elucidate further research opportunities.

Methods: A systematic search for relevant articles was performed in five databases from inception to 13 May 2022. Included studies applied the SVI to analyze outcomes in cancer patients. Study characteristics, patent populations, data sources, and outcomes were extracted from each article. This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Results: In total, 31 studies were included. Along the cancer care continuum, five applied the SVI to examine geographic disparities in potentially cancer-causing exposures; seven in cancer diagnosis; fourteen in cancer treatment; nine in treatment recovery; one in survivorship care; and two in end-of-life care. Fifteen examined disparities in mortality.

Conclusion: In highlighting place-based disparities in patient outcomes, the SVI represents a promising tool for future oncology research. As a reliable geocoded dataset, the SVI may inform the development and implementation of targeted interventions to prevent cancer morbidity and mortality at the neighborhood level.

Citing Articles

Social vulnerability index associated with higher COVID-19 seroprevalence in Nigeria.

Blanco N, Lawal O, Jumare J, Riley C, Onyemata J, Kono T Glob Health Action. 2025; 17(1):2446043.

PMID: 39834339 PMC: 11753008. DOI: 10.1080/16549716.2024.2446043.

Lower Commercial Rates for Breast Surgical Procedures are Associated with Socioeconomic Disadvantage: A Transparency in Coverage Analysis.

Rochlin D, Wang Y, Amakiri U, Levy J, Boe L, Sheckter C Ann Surg Oncol. 2024; .

PMID: 39719512 DOI: 10.1245/s10434-024-16738-z.

Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort.

Montgomery K, McLeod M, DePalo D, Dugan M, Zager J, Elleson K Ann Surg Oncol. 2024; 32(3):1453-1462.

PMID: 39576454 PMC: 11811232. DOI: 10.1245/s10434-024-16498-w.

Analyzing the Social Vulnerability Index With Metabolic Surgery.

Mathai S, Garofalo D, Myers Q, Heron C, Clair V, Bonner I J Surg Res. 2024; 303:164-172.

PMID: 39357347 PMC: 11778274. DOI: 10.1016/j.jss.2024.09.002.

Neighborhood vulnerability and associations with poor health-related quality of life among adult survivors of childhood cancer.

Choi J, Horan M, Brinkman T, Srivastava D, Ness K, Armstrong G JNCI Cancer Spectr. 2024; 8(6).

PMID: 39288319 PMC: 11549958. DOI: 10.1093/jncics/pkae088.

References

Smith B, Smith G, Hurria A, Hortobagyi G, Buchholz T . Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009; 27(17):2758-65. DOI: 10.1200/JCO.2008.20.8983. View

Rice D, Hyer J, Diaz A, Pawlik T . End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma. Ann Surg Oncol. 2021; 28(9):5414-5422. DOI: 10.1245/s10434-021-09606-7. View

Freeman H . Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin. 2004; 54(2):72-7. DOI: 10.3322/canjclin.54.2.72. View

Ward E, Jemal A, Cokkinides V, Singh G, Cardinez C, Ghafoor A . Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54(2):78-93. DOI: 10.3322/canjclin.54.2.78. View

Zavala V, Bracci P, Carethers J, Carvajal-Carmona L, Coggins N, Cruz-Correa M . Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2020; 124(2):315-332. PMC: 7852513. DOI: 10.1038/s41416-020-01038-6. View

Notley C, Ward E, Kassianos A, Kurti A, Muirhead F, Nostikasari D . Negotiating cancer preventative health behaviours and adapting to motherhood: the role of technology in supporting positive health behaviours. Int J Qual Stud Health Well-being. 2020; 15(1):1811533. PMC: 7534276. DOI: 10.1080/17482631.2020.1811533. View

McAlarnen L, Tsaih S, Aliani R, Simske N, Hopp E . Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum. Gynecol Oncol. 2021; 162(1):4-11. PMC: 8111476. DOI: 10.1016/j.ygyno.2021.04.037. View

Azap R, Paredes A, Diaz A, Hyer J, Pawlik T . The association of neighborhood social vulnerability with surgical textbook outcomes among patients undergoing hepatopancreatic surgery. Surgery. 2020; 168(5):868-875. DOI: 10.1016/j.surg.2020.06.032. View

Grabinski V, Brawley O . Disparities in Breast Cancer. Obstet Gynecol Clin North Am. 2022; 49(1):149-165. DOI: 10.1016/j.ogc.2021.11.010. View

10.

Abbas A, Hyer J, Pawlik T . Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery. Ann Surg Oncol. 2020; 28(4):1918-1926. DOI: 10.1245/s10434-020-09227-6. View

11.

Adams A, Benner R, Riggs T, Chescheir N . Use of the STROBE Checklist to Evaluate the Reporting Quality of Observational Research in Obstetrics. Obstet Gynecol. 2018; 132(2):507-512. DOI: 10.1097/AOG.0000000000002689. View

12.

OKeefe E, Meltzer J, Bethea T . Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. Front Public Health. 2015; 3:51. PMC: 4398881. DOI: 10.3389/fpubh.2015.00051. View

13.

Parks R, Benavides J, Anderson G, Nethery R, Navas-Acien A, Dominici F . Association of Tropical Cyclones With County-Level Mortality in the US. JAMA. 2022; 327(10):946-955. PMC: 8905400. DOI: 10.1001/jama.2022.1682. View

14.

Hawley J, Sun T, Chism D, Duma N, Fu J, Gatson N . Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Netw Open. 2022; 5(1):e2142046. PMC: 8728628. DOI: 10.1001/jamanetworkopen.2021.42046. View

15.

Kurani S, McCoy R, Lampman M, Doubeni C, Finney Rutten L, Inselman J . Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest. JAMA Netw Open. 2020; 3(3):e200618. PMC: 7063513. DOI: 10.1001/jamanetworkopen.2020.0618. View

16.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

17.

Papageorge M, Woods A, de Geus S, Ng S, Paasche-Orlow M, Segev D . Beyond insurance status: the impact of Medicaid expansion on the diagnosis of Hepatocellular Carcinoma. HPB (Oxford). 2022; 24(8):1271-1279. DOI: 10.1016/j.hpb.2021.12.020. View

18.

Diaz A, Dalmacy D, Hyer J, Tsilimigras D, Pawlik T . Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer. J Surg Oncol. 2021; 124(5):886-893. DOI: 10.1002/jso.26588. View

19.

Roth R, Barsi E . The community need index. A new tool pinpoints health care disparities in communities throughout the nation. Health Prog. 2005; 86(4):32-8. View

20.

Brown J, Asumeng C, Greenwald D, Weissman M, Zauber A, Striplin J . Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening. BMC Public Health. 2021; 21(1):1280. PMC: 8247120. DOI: 10.1186/s12889-021-11330-6. View